LYKA LABS
LYKALABS · NSE
76.60
+0.35 (+0.46%)
as of 30 Oct 2026 close
Open
77.77
High
77.77
Low
76.60
Prev close
76.25
52w high
98.25
31 Oct 2025
52w low
44.10
30 Mar 2026
VWAP
77.52
Delivery %
—
n/a
Volume 6,475 · turnover ₹5.02 L · NSE bhavcopy (official close) · history since 04 Jan 2010
- Market cap
- ₹277 cr
- ISIN
- INE933A01014
- Series
- BE
- Listed on NSE
- 08 Feb 1995
- Face value
- ₹10
- F&O
- No
Source: NSE equity master · as of 31 Oct 2026 · market cap = shares (30 Sept 2026 filing) × close
Market cap
₹277 cr
P/B
3.06
BV ₹25
ROE (TTM)
—
Debt / equity
0.49
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
—
Net profit TTM
—
Net margin TTM
—
EV / EBITDA
—
Interest cover
—
Revenue growth
—
latest quarter YoY
Profit growth
—
latest quarter YoY
Dividend yield
—
last 12 months
Standalone · last four quarters to 2026-09-30 · balance sheet 2026-09-30 · tap a tile for the formula
Daily · NSE EOD
Shareholding · as of 30 Sept 2026
Promoters
58.45%
+0.00 pp QoQ
Public
41.55%
Promoter pledge
0.00%
of promoter shares
FPIs 0.15%
DIIs 0.66%
Mutual funds 0.01%
Insurance 0.28%
Retail 31.22%
Government —
26-06
26-09
Promoter share by quarter · source: NSE shareholding filings (XBRL). DIIs include mutual funds and insurers.
Quarterly results · Consolidated · latest 30 Sept 2026
filed 30 Oct 2026, 06:02 pm IST| ₹ crore | Jun 26* | Sept 26* |
|---|---|---|
| Revenue | 42 | 44 |
| Other income | 0 | 1 |
| Total expenses | 41 | 44 |
| Operating margin | 10.7% | 8.0% |
| Finance costs | 1 | 1 |
| Depreciation | 2 | 2 |
| Profit before tax | 2 | 1 |
| Tax | -0 | -0 |
| Net profit | 2 | 1 |
| Net margin | 4.8% | 2.9% |
| EPS (₹) | 0.57 | 0.36 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison